The who, the what, and the how: A description of strategies and lessons learned to expand access to medications for opioid use disorder in rural America

References

• U.S. Department of Health and Human Services. What is the U.S. opioid epidemic. https://www.hhs.gov/opioids/about-the-epidemic/index.html. Published 2019. Accessed October 4, 2019.
   Google Scholar
• Centers for Disease Control. Understanding the epidemic. Wide-ranging online data for epidemiologic research (WONDER) Web site. https://www.cdc.gov/drugoverdose/epidemic/index.html. Published 2017. Accessed August 13, 2019.
   Google Scholar
• Chou R, Korthuis PT, Weimer M, et al. Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings. Rockville, MD: Agency for Healthcare Research and Quality (US); 2016.
   Google Scholar
• World Health Organization Department of Mental Health Substance Abuse. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, Switzerland: World Health Organization; 2009.
   Google Scholar
• Providers Clinical Support System. Overview of medication assisted treatment. https://pcssnow.org/medication-assisted-treatment/. Published 2019. Accessed November 13, 2019.
   Google Scholar
• Ghertner R. US trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018. Drug Alcohol Depend. 2019;204:107527.
   PubMed Web of Science ®Google Scholar
• Andrilla CHA, Coulthard C, Patterson DG. Prescribing practices of rural physicians waivered to prescribe buprenorphine. Am J Prev Med. 2018; 54(6 Suppl 3):S208–S214.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. 2014 Buprenorphine Summit, Report of Proceedings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
   Google Scholar
• Physician Assistant Education Association. MAT waiver training initiative. https://paeaonline.org/mat-waiver-training-initiative/. Published 2019. Accessed September 15, 2019.
   Google Scholar
• Health Resources & Services Administration. How to receive medication-assisted treatment (MAT) training. https://nhsc.hrsa.gov/loan-repayment/receive-medication-assisted-treatment-training. Published 2019. Accessed September 15, 2019.
   Google Scholar
• American Society of Addiction Medicine. The ASAM treatment of opioid use disorder course. https://elearning.asam.org/buprenorphine-waiver-course. Published 2019. Accessed September 15, 2019.
   Google Scholar
• Levin FR, Bisaga A, Sullivan MA, Williams AR, Cates‐Wessel K. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic. Am J Addict. 2016;25(8):603–609.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. Increasing access to medication-assisted treatment (MAT) in rural primary care practices (R18). https://grants.nih.gov/grants/guide/rfa-files/rfa-hs-16-001.html. Published 2015. Accessed September 15, 2019.
   Google Scholar
• Agency for Healthcare Research and Quality. Primary care medication-assisted treatment for opioid use disorder grantees. https://integrationacademy.ahrq.gov/about/opioids-substance-use/primary-care-medication-assisted-treatment-opioid-use-disorder-grantees. Published 2020. Accessed April 30, 2020.
   Google Scholar
• Cochran G, Cole ES, Warwick J, et al. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers. Addict Sci Clin Pract. 2019;14(1):25.
   PubMedGoogle Scholar
• Shea CM, Gertner AK, Green SL. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: a qualitative study. Subst Abus. 2021;42(1):54–11.
   PubMed Web of Science ®Google Scholar
• Salvador JG, Bhatt SR, Jacobsohn VC, et al. Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports. Substance Abuse. 2020;1–8.doi: 10.1080/08897077.2020.1806184.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Increasing access to medication-assisted treatment in rural primary care practices - R18 grants. https://integrationacademy.ahrq.gov/sites/default/files/2020-07/Grant_Summary_OK.pdf. Published 2020. Accessed November 16, 2020.
   Google Scholar
• Gordon AJ, Drexler K, Hawkins EJ, et al. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Subst Abus. 2020;41(3):275–282.
   PubMed Web of Science ®Google Scholar
• Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011;364(23):2199–2207.
   PubMed Web of Science ®Google Scholar
• Ober AJ, Watkins KE, Hunter SB, Lamp K, Lind M, Setodji CM. An organizational readiness intervention and randomized controlled trial to test strategies for implementing substance use disorder treatment into primary care: SUMMIT study protocol. Implement Sci. 2015;10:66.
   PubMed Web of Science ®Google Scholar
• Hagedorn H, Kenny M, Gordon AJ, et al. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addict Sci Clin Pract. 2018;13(1):25.
   PubMedGoogle Scholar
• Polydorou S, Gunderson EW, Levin FR. Training physicians to treat substance use disorders. Curr Psychiatry Rep. 2008;10(5):399–404.
   PubMedGoogle Scholar
• Hutchinson E, Catlin M, Andrilla CHA, Baldwin L-M, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med. 2014;12(2):128–133.
   PubMed Web of Science ®Google Scholar
• McCarty D, Rieckmann T, Green C, Gallon S, Knudsen J. Training rural practitioners to use buprenorphine: using The Change Book to facilitate technology transfer. J Subst Abuse Treat. 2004;26(3):203–208.
   PubMed Web of Science ®Google Scholar
• Walley AY, Alperen JK, Cheng DM, et al. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med. 2008;23(9):1393–1398.
   PubMed Web of Science ®Google Scholar
• Berk J. To help providers fight the opioid epidemic, “X the X Waiver”. Health Affairs. https://www.healthaffairs.org/do/10.1377/hblog20190301.79453/full/. Published 2019. Accessed October 24, 2019.
   Google Scholar
• Frank JW, Wakeman SE, Gordon AJ. No end to the crisis without an end to the waiver. Subst Abus. 2018;39(3):263–265.
   PubMed Web of Science ®Google Scholar
• Hunt JB, Curran G, Kramer T, et al. Partnership for implementation of evidence-based mental health practices in rural federally qualified health centers: theory and methods. Prog Community Health Partnersh. 2012;6(3):389–398.
   PubMedGoogle Scholar
• Netherland J, Botsko M, Egan JE, Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36(3):244–251.
   PubMed Web of Science ®Google Scholar
• Barry DT, Irwin KS, Jones ES, et al. Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med. 2009;24(2):218–225.
   PubMed Web of Science ®Google Scholar
• LaBelle CT, Han SC, Bergeron A, Samet JH. Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the Massachusetts collaborative care model in community health centers. J Subst Abuse Treat. 2016;60:6–13.
   PubMed Web of Science ®Google Scholar
• DiPiero A, Dorr DA, Kelso C, Bowen JL. Integrating systematic chronic care for diabetes into an academic general internal medicine resident-faculty practice. J Gen Intern Med. 2008;23(11):1749–1756.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23(12):1966–1972.
   PubMed Web of Science ®Google Scholar
• Alford DP, LaBelle CT, Kretsch N, et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011;171(5):425–431.
   PubMedGoogle Scholar
• Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 2005–2015. Rockville, MD: National Admissions to Substance Abuse Treatment Services; 2017.
   Google Scholar
• Cole ES, DiDomenico E, Cochran G, et al. The role of primary care in improving access to medication-assisted treatment for rural medicaid enrollees with opioid use disorder. J Gen Intern Med. 2019;34(6):936–943.
   PubMed Web of Science ®Google Scholar